Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

@article{Joyner2021ConvalescentPA,
  title={Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19},
  author={Michael J. Joyner and Rickey E. Carter and Jonathon W. Senefeld and Stephen A Klassen and J R Mills and Patrick W. T. Johnson and Elitza S. Theel and Chad C Wiggins and K. A. Bruno and Allan M Klompas and Elizabeth R. Lesser and Katie L. Kunze and Matthew A Sexton and Juan C Diaz Soto and Sarah E Baker and John R A Shepherd and Noud van Helmond and Nicole C. Verdun and Peter Marks and Camille M. van Buskirk and Jeffrey L. Winters and James R. Stubbs and Robert F. Rea and David O. Hodge and Vitaly Herasevich and Emily R Whelan and Andrew J Clayburn and Kathryn F Larson and Juan G Ripoll and Kylie J Andersen and Matthew R Buras and Matthew N P Vogt and Joshua J Dennis and Riley J Regimbal and Philippe R Bauer and Janis E. Blair and Nigel S Paneth and DeLisa Fairweather and R. Scott Wright and Arturo Casadevall},
  journal={The New England Journal of Medicine},
  year={2021}
}
Abstract Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death is unknown. Methods In a retrospective study based on a U.S… Expand
Impact of convalescent plasma therapy on SARS CoV-2 antibody profile in COVID-19 patients
TLDR
It is proposed that treatment of COVID-19 patients with convalescent plasma should be carefully targeted, and effectiveness of treatment may depend on the clinical and immunological status of COIDs patients as well as the quality of the antibodies in the convalescence plasma. Expand
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
TLDR
It is suggested that near sourced plasma is superior to distantly sourced plasma, which has implications for interpreting the results of clinical studies and designing effective treatment of COVID-19 patients as additional local variant are likely to emerge. Expand
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients
TLDR
Common cold coronavirus spike IgG antibodiesAnti-HCoV-OC43 and anti-H coV-HKU1 antibodies provide a promising therapeutic target for monoclonal antibody production and may target a common domain for SARS- CoV-2 and other coronaviruses. Expand
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
TLDR
Common cold coronavirus spike IgG antibodiesAnti-HCoV-OC43 and anti-H coV-HKU1 antibodies provide a promising therapeutic target for monoclonal antibody production and may target a common domain for SARS- CoV-2 and other coronaviruses. Expand
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.
TLDR
Convalescent plasma did not reduce the risk of intubation or death at 30 d in hospitalized patients with COVID-19, and transfusion of convalescence plasma with unfavorable antibody profiles could be associated with worse clinical outcomes compared to standard care. Expand
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
TLDR
The data indicate convalescent plasma therapy in humans may be an effective strategy provided donor sera contain high anti-SARS-CoV-2 neutralizing titers given in early stages of disease. Expand
Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
TLDR
Convalescent plasma (CP) therapy may be a potential therapeutic option in severe or critically ill patients with COVID-19 and showed a higher increase in Ct values at 24 h and 72 h after CP therapy compared to controls with similar initial Ct values. Expand
Effect of time and titer in convalescent plasma therapy for COVID-19
TLDR
This meta-analysis might promote convalescent plasma usage in patients with early stage COVID-19 in further RCTs to maximize its benefit in decreasing mortality, especially in less affluent countries. Expand
Use of convalescent plasma in COVID‐19 patients with immunosuppression
TLDR
Evidence is provided suggesting a mortality benefit and rapid clinical improvement in patients with several forms of immunosuppression following COVID‐19 convalescent plasma transfusion and the utility of convalescence plasma or other forms of antibody therapy in immune‐deficient and immune‐suppressed patients with CO VID‐19 warrants further investigation. Expand
Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia
TLDR
Convalescent plasma treatment in patients over 80 years old with COVID-19 pneumonia was well tolerated but did not present a statistically significant difference in hospital mortality, ICU admission, or length of hospitalization. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 11 REFERENCES
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China
TLDR
SARS-CoV-2 may exist in a population without clinical cases for a long period in WH and other places of China; a large amount of asymptomatic carriers of SARS- Cov-2 existed after elimination of clinical cases of COVID-19 in Wuhan City. Expand
Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany
  • T. Weinberger, J. Steffen, +12 authors M. Klein
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2021
TLDR
The risk of SARS-CoV-2 infection for front-line health care workers was increased during the first pandemic wave in Southern Germany and Stringent measures for infection control are essential to protect all patient-facing staff during the ongoing pandemic. Expand
Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study
TLDR
The widespread reported use of face masks combined with physical distancing increases the odds of SARS-CoV-2 transmission control, suggesting that supplemental public health interventions are needed to maximise adoption and help to curb the ongoing epidemic. Expand
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
TLDR
The 4C Deterioration model has strong potential for clinical utility and generalisability to predict clinical deterioration and inform decision making among adults hospitalised with COVID-19. Expand
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis.
TLDR
The results suggest that saliva NAAT diagnostic accuracy is similar to that of nasopharyngeal swab NAAT, especially in the ambulatory setting, and support larger-scale research on the use of salivaNAAT as an alternative to nasoph throat swabs. Expand
Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations
TLDR
Life expectancy at birth and at age 65 for 2020, for the total US population and by race and ethnicity, is estimated, using four scenarios of deaths – one in which the CO VID-19 pandemic had not occurred and three including COVID-19 mortality projections produced by the Institute for Health Metrics and Evaluation. Expand
Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)
TLDR
The current study used molecular docking, molecular dynamics and protein-protein interaction simulations to predict drugs from the Drug Bank that can bind to the SARS-CoV-2 spike protein interacting surface on the human angiotensin-converting enzyme 2 (hACE2) receptor. Expand
How does public knowledge, attitudes, and behaviors correlate in relation to COVID-19? A community-based cross-sectional study in Nepal
TLDR
A need for targeted community awareness interventions for the most vulnerable populations, men, those with no school education, the elderly, and people living in rural areas is suggested. Expand
Exposome changes in primary school children following the wide population non-pharmacological interventions implemented due to COVID-19 in Cyprus: a national survey
TLDR
The initial NPI measures may have affected children exposome profile in the following months, by altering their diet, physical activity, sedentary lifestyle and hand hygiene habits, and the odds of compliance were lower with days elapsing from school re-opening, living in smaller town and using antiseptic more frequently pre-lockdown. Expand
Communicating Awareness About COVID-19 Through Songs: An Example From Ghana
TLDR
It is shown that songs have the potential as a method for rapidly sharing information about emerging public health crises and examining song lyrics can still be useful in understanding local attitudes toward COVID-19, as well as strategies for promoting preventive behaviors. Expand
...
1
2
...